Long-term hemoglobin A1c changes with apremilast in patients with psoriasis and psoriatic arthritis: Pooled analysis of phase 3 ESTEEM and PALACE trials and phase 3b LIBERATE trial

doi:10.1016/j.jaad.2019.06.346

Long-term hemoglobin A1c changes with apremilast in patients with psoriasis and psoriatic arthritis: Pooled analysis of phase 3 ESTEEM and PALACE trials and phase 3b LIBERATE trial

https://doi.org/10.1016/j.jaad.2019.06.346

Copy DOI

Journal: Journal of the American Academy of Dermatology	Publication Date: Aug 21, 2019
Citations: 6

#Apremilast In Patients #Hemoglobin A1c Changes + Show 8 more

Abstract
Full-Text
Similar Papers

Abstract

Long-term hemoglobin A1c changes with apremilast in patients with psoriasis and psoriatic arthritis: Pooled analysis of phase 3 ESTEEM and PALACE trials and phase 3b LIBERATE trial

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title

Journal

Date

Author

View more papers

More From: Journal of the American Academy of Dermatology

Paper Title

Journal

Date

Author

View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.